Effect of stem cell turnover rates on protection against cancer and aging

被引:34
作者
Wodarz, Dominik [1 ]
机构
[1] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92697 USA
关键词
stem cells; tissue architecture; tissue design; cancer; aging; mathematical models; tradeoff; evolution; mathematical model;
D O I
10.1016/j.jtbi.2006.10.013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tissue stem cells are responsible for replenishing and maintaining a population of cells which make up a functioning organ. They divide by asymmetric cell division where one daughter remains a stem cell while the other daughter becomes a transit cell, which divides a defined number of times and differentiates. A fully differentiated cell has a finite life-span. A tissue can be maintained by various strategies. Stem cells can divide often and differentiated cells die often (fast turnover). Alternatively, stem cells can divide infrequently, and the differentiated cells are long lived (slow turnover). Genetic alterations and mutations can interfere with tissue homoeostasis. Mutations can induce senescence and apoptosis, and this can result in a reduction of the number of functioning tissue cells which could correlate with tissue aging. Alternatively, mutations can result in the carcinogenic transformation of cells and the formation of a tumour. Using mathematical models, I find that the cellular turnover rate affects the ability of genetic alterations to induce aging and the development of cancer. If mutations occur as a result of errors during cell division, the model suggests that a low cellular turnover rate protects both against aging and the development of cancer. On the other hand, if mutations occur independent from cell division (e.g. if DNA is hit by damaging agents), I find that a high cellular turnover rate protects against aging, while it promotes the development of cancer. Implications for optimal tissue design are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:449 / 458
页数:10
相关论文
共 48 条
[1]  
Adam J. A., 1997, A survey of models for tumor-immune system dynamics, DOI 10.1007/978-0-8176-8119-7
[2]   Stem cells: the intestinal stem cell as a paradigm [J].
Bach, SP ;
Renehan, AG ;
Potten, CS .
CARCINOGENESIS, 2000, 21 (03) :469-476
[3]   Stem cells, aging, and cancer: inevitabilities and outcomes [J].
Bell, DR ;
Van Zant, G .
ONCOGENE, 2004, 23 (43) :7290-7296
[4]   A PMLRAR alpha transgene initiates murine acute promyelocytic leukemia [J].
Brown, D ;
Kogan, S ;
Lagasse, E ;
Weissman, I ;
Alcalay, M ;
Pelicci, PG ;
Atwater, S ;
Bishop, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2551-2556
[5]   Somatic stem cells and the kinetics of mutagenesis and carcinogenesis [J].
Cairns, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10567-10570
[6]   Aging, tumor suppression and cancer: high wire-act! [J].
Campisi, J .
MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (01) :51-58
[7]   Cancer and ageing: Rival demons? [J].
Campisi, J .
NATURE REVIEWS CANCER, 2003, 3 (05) :339-349
[8]   Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors [J].
Campisi, J .
CELL, 2005, 120 (04) :513-522
[9]  
CAMPISI J, 2002, SCI AGING KNOWLEDGE, P53
[10]   A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences [J].
d'Onofrio, A .
PHYSICA D-NONLINEAR PHENOMENA, 2005, 208 (3-4) :220-235